Member Info for Toukankahmoon

At the risk of a roasting, IMHO:

1. There will be no takeover

2. We will get the anticipated progress RNSs as the trials continue over next few months

3. Hopefully mid year ish we will get excellent results at the completion of the fortnightly trial.

4. This will precipitate a lucrative licensing deal for AVA3996 which will fund AVA6000 P2 trials and AVA3996 P1 trials.

5. And the SP will move to - well who the hell knows based on previous market reaction.

Have a good weekend watching the rugger everybody.

Yet again the rampers turn to conspiracy theories and deals to be announced imminently no doubt with NDAs in place preventing Avacta from sharing the good news and keeping radio silence. Talk about clutching at straws. Just more wishful thinking. There is a more obvious reason for silence and that is there is nothing to RNS. Certainly the market thinks that is the case. Let’s face it when the BOD has been quiet in the past, the news when it comes has never been unequivocally good news.

When good news is about to happen we will all know. There will be leaks and the SP will start to move very quickly. About mid year I expect.

So Strangy you are just another delusional cheerleader on here that cannot entertain any question ing over the poor communication from Avacta

Since when is it a debate?

The worst offenders just swear and name call.

Laugh at the FUDsters and risk losing your house or laugh at the rampers and risk not making as much money as you might. Hard choice

Of course it will

Timster

I couldn’t paste the whole article. There were many more examples. My point is so many times the science is not enough on its own to guarantee commercial success. It needs an excellent senior team to deliver. Hopefully Avacta are getting close to having that team in place.

But I was challenging the title of the thread. It isn’t all about the data, the people are just as important.

Going back to the stupid title of this thread:

****************+****+++*****

Commercialization is widely acknowledged to be a critical step in the technological innovation process. It is a very risky activity, as shown by the disappointing success rates for fully commercialized new products [1] and by the huge number of innovations that, although functionally superior to competing ones, turned out to be far less successful, mainly because of a poor commercialization strategy.

Moreover, commercialization is often the single costliest stage of the whole innovation process [3]; for example, Gillette spent about $110 million on advertising for its new Sensor in the first year after launch, while the total R&D expenses amounted to $200 million.

************+***++********

The science is only part of it.

Tim

You know I’m not. I’ve said I think there is little risk and potentially huge reward.

It’s only the pratts that keep saying it should be £20 right now that wind me up. And you know that.

Problem is AVA6000 has produced excellent results but on a statistically insignificant number of patients. The drug it was developed from was not targeting the tumour precisely enough. The huge potential profit is years away bearing in mind that initial profit will need to be used to help fund development of the subsequent drugs. So we are trying to calculate the present value of some figure that is years away.

At the end of the day it’s an assessment of risk versus reward. The professionals reckon that is about £1. but of course the (mainly) amateurs on here know better. And have done for 5 years.

Bella

The point I’ve been making to hoots of derision from the usual suspects.

Christina has been brought in to assist the deal. Might not be Novartis though

Also have to remember that any TO of Avacta by BP would then mean we’d be invested across a larger number of product lines. So any profits diluted in future. I’d sell and move on. A licence deal would be totally different scenario.

Michbens

That’s ok he’s relatively polite and harmless compared to some

Oilly . . . . wishful thinking?

Surely not on this BB. Only well researched LTH fact based posts on this BB.

Rampers just like little school kids

It’s got to be. It’s been so long coming

Nah just wait until Christina’s got her feet under the table

. . . just asking those that might know for a friend

I’ve already said that the Novartis deal was only going to go ahead once they got their girl in place.

Watch this space.

Oh don’t spoil it I have to have some conspiracy theories to blame the low SP on.